9.35
-0.91
(-8.87%)
At close: January 10 at 4:00:02 PM EST
9.35
0.00
(0.00%)
After hours: January 10 at 4:01:07 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-51,057.00
-47,430.00
-50,829.00
-15,304.00
-13,541.00
Investing Cash Flow
-122,165.00
-25,975.00
-6,299.00
-1,724.00
-284.00
Financing Cash Flow
163,218.00
24,391.00
-1,264.00
152,754.00
37,395.00
End Cash Position
56,139.00
53,762.00
102,776.00
161,168.00
25,442.00
Income Tax Paid Supplemental Data
--
83.00
--
--
--
Capital Expenditure
-1,214.00
-3,258.00
-6,299.00
-1,724.00
-284.00
Issuance of Capital Stock
--
--
--
154,612.00
34,854.00
Issuance of Debt
--
--
--
--
3,000.00
Repurchase of Capital Stock
--
-12.00
-5.00
--
--
Free Cash Flow
-52,271.00
-50,688.00
-57,128.00
-17,028.00
-13,825.00
12/31/2020 - 7/19/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RAPP Rapport Therapeutics, Inc.
14.81
-11.26%
BOLD Boundless Bio, Inc.
2.4200
-3.20%
BCAX Bicara Therapeutics Inc.
14.38
-5.70%
CTNM Contineum Therapeutics, Inc.
13.29
-0.60%
ACTU Actuate Therapeutics, Inc. Common stock
8.30
+3.75%
SEPN Septerna, Inc.
17.99
-13.72%
CLYM Climb Bio, Inc.
2.0000
+6.95%
DNTH Dianthus Therapeutics, Inc.
24.20
-5.39%
MBX MBX Biosciences, Inc.
13.69
-5.65%
ACRV Acrivon Therapeutics, Inc.
5.47
-10.33%